CytoDyn Inc. Quarterly Deferred Tax Assets, Gross in USD from Q2 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
CytoDyn Inc. quarterly Deferred Tax Assets, Gross history and growth rate from Q2 2019 to Q2 2024.
  • CytoDyn Inc. Deferred Tax Assets, Gross for the quarter ending May 31, 2024 was $129M, a 0.02% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $129M +$28K +0.02% May 31, 2024 10-K 2024-08-15
Q2 2023 $129M +$11M +9.37% May 31, 2023 10-K 2024-08-15
Q2 2022 $118M +$34.4M +41.3% May 31, 2022 10-K 2023-09-14
Q2 2021 $83.3M +$23.1M +38.5% May 31, 2021 10-K 2022-08-15
Q2 2020 $60.1M +$17M +39.4% May 31, 2020 10-K 2021-07-30
Q2 2019 $43.1M May 31, 2019 10-K 2020-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.